Lyell Immunopharma Q1 2026 Earnings Narrower Loss Beats Estimates as Pipeline Progress Continues GPI Q1 2026 Earnings EPS Misses Estimates Despite Stock Uptick Live Ventures Q1 2026 Earnings Diversified Holding Company Reports Positive EPS Amid Market Challenges SSM Q1 2026 Earnings WiderthanExpected Loss Amid No Revenue Disclosure PARR Q1 2026 Earnings Earnings Miss Weighs on Results but Stock Edges Higher VSE Corporation VSEC Shows Strength Stock Advances 21 Amid Positive Momentum Tyson Foods TSN Faces Selling Pressure Testing Key Support Levels aTyr Pharma ATYR Slips 122 Approaching Key Support at 046 Koss Corporation KOSS Rallies 554 Testing Key Resistance at 440 SEE Q4 2025 Earnings EPS Beats Estimates Amid Cautious Outlook